Skip to main content
Premium Trial:

Request an Annual Quote

Intrexon Raises $66.9M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Intrexon has raised $66.9 million, according to a document filed with the US Securities and Exchange Commission last week.

Based in Blacksburg, Va., the genetic engineering firm did not say how the funds will be used but said the offering was not made in connection with a business combination transaction such as a merger.

A total of 82 investors participated in the offering, though Intrexon did not identify them. The company, which had been called Genomatix, said the date of the first sale for the offering was Feb. 19, 2010.

A company spokesman declined to comment on the transaction.

In January 2010, Intrexon raised $25 million in equity financing.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.